News & Information

Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

This study will evaluate the effectiveness of a test called MCV in guiding phlebotomy (blood drawing) therapy in patients with hemochromatosis an inherited disorder that causes too much iron…

December 22, 2017  /  Comments Off on Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

La Jolla Pharmaceutical Company Announces Drug Study

La Jolla Pharmaceutical Company today announced the initiation of LJ401-HH01, a Phase 2 clinical study of LJPC‑401 (synthetic human hepcidin) in patients with hereditary hemochromatosis…

December 22, 2017  /  Comments Off on La Jolla Pharmaceutical Company Announces Drug Study

Our New Awareness Poster

July is National Hemochromatosis Awareness Month and in an effort to raise awareness we are unveiling our new poster for use in doctor’s offices, clinics, and hospitals.

July 4, 2016  /  Comments Off on Our New Awareness Poster